(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YARS1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1316914 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of YARS1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1316915 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YARS1 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:1316915 6480464 ethylene dichloride results in decreased expression of YARS1 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of YARS1 mRNA CTD PMID:20551477 17alpha-ethynylestradiol multiple interactions ISO RGD:1316915 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YARS1 mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of YARS1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of YARS1 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1316914 6480464 Estradiol results in increased expression of YARS1 mRNA CTD PMID:20106945 , PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1316914 6480464 2 more ... CTD PMID:19095052 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1316914 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316915 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YARS1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of YARS1 mRNA CTD PMID:33387578 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of YARS1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of YARS1 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of YARS1 protein, alpha-Chlorohydrin results in increased expression of YARS1 protein CTD PMID:26597043 , PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1316914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1316914 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of YARS1 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of YARS1 mRNA CTD PMID:21346803 5-fluorouracil multiple interactions ISO RGD:1316914 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA] CTD PMID:15016801 acrylamide increases expression ISO RGD:1316914 6480464 Acrylamide results in increased expression of YARS1 mRNA CTD PMID:32763439 adefovir pivoxil decreases expression ISO RGD:1316914 6480464 adefovir dipivoxil results in decreased expression of YARS1 mRNA CTD PMID:25596134 aflatoxin B1 decreases methylation ISO RGD:1316914 6480464 Aflatoxin B1 results in decreased methylation of YARS1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1316914 6480464 Tretinoin results in decreased expression of YARS1 mRNA CTD PMID:33167477 AM-251 increases expression ISO RGD:1316914 6480464 AM 251 results in increased expression of YARS1 mRNA CTD PMID:16500647 aristolochic acid A increases expression ISO RGD:1316914 6480464 aristolochic acid I results in increased expression of YARS1 protein CTD PMID:33212167 benzo[a]pyrene increases expression ISO RGD:1316915 6480464 Benzo(a)pyrene results in increased expression of YARS1 mRNA CTD PMID:20504355 benzo[a]pyrene affects methylation ISO RGD:1316914 6480464 Benzo(a)pyrene affects the methylation of YARS1 exon CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1316914 6480464 Benzo(a)pyrene results in decreased expression of YARS1 protein CTD PMID:32717239 bisphenol A affects expression ISO RGD:1316914 6480464 bisphenol A affects the expression of YARS1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1316915 6480464 bisphenol A results in increased expression of YARS1 mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of YARS1 mRNA CTD PMID:32145629 , PMID:34947998 bisphenol A increases expression ISO RGD:1316914 6480464 bisphenol A results in increased expression of YARS1 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of YARS1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1316914 6480464 bisphenol A results in decreased expression of YARS1 mRNA CTD PMID:20678512 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of YARS1 mRNA CTD PMID:26496021 Bisphenol B increases expression ISO RGD:1316914 6480464 bisphenol B results in increased expression of YARS1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1316914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1316914 6480464 bisphenol F results in increased expression of YARS1 protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of YARS1 protein CTD PMID:28903499 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of YARS1 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1316914 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA CTD PMID:29432896 cadmium dichloride increases expression ISO RGD:1316914 6480464 Cadmium Chloride results in increased expression of YARS1 mRNA CTD PMID:25596134 cadmium dichloride affects localization ISO RGD:1316914 6480464 Cadmium Chloride affects the localization of YARS1 protein CTD PMID:18261755 carbamazepine affects expression ISO RGD:1316914 6480464 Carbamazepine affects the expression of YARS1 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO RGD:1316914 6480464 CGP 52608 promotes the reaction [RORA protein binds to YARS1 gene] CTD PMID:28238834 chloroacetaldehyde decreases expression ISO RGD:1316914 6480464 chloroacetaldehyde results in decreased expression of YARS1 mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1316914 6480464 chloropicrin results in increased expression of YARS1 mRNA CTD PMID:26352163 cidofovir anhydrous affects expression ISO RGD:1316914 6480464 Cidofovir affects the expression of YARS1 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1316914 6480464 Cisplatin results in decreased expression of YARS1 mRNA, Cisplatin results in decreased expression of YARS1 protein CTD PMID:20540955 , PMID:25596134 cisplatin affects response to substance ISO RGD:1316914 6480464 YARS1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clodronic acid decreases expression ISO RGD:1316914 6480464 Clodronic Acid results in decreased expression of YARS1 mRNA CTD PMID:25596134 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of YARS1 protein CTD PMID:16470657 copper(II) sulfate increases expression ISO RGD:1316914 6480464 Copper Sulfate results in increased expression of YARS1 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1316914 6480464 Cyclosporine results in increased expression of YARS1 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of YARS1 mRNA CTD PMID:25596134 dexamethasone multiple interactions ISO RGD:1316914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA CTD PMID:28628672 dioxygen decreases expression ISO RGD:1316914 6480464 Oxygen deficiency results in decreased expression of YARS1 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1316915 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of YARS1 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1316914 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of YARS1 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1316914 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of YARS1 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:1316915 6480464 epoxiconazole results in decreased expression of YARS1 mRNA CTD PMID:35436446 fenofibrate increases expression ISO RGD:1316914 6480464 Fenofibrate results in increased expression of YARS1 mRNA CTD PMID:25596134 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of YARS1 mRNA CTD PMID:25596134 flutamide increases expression EXP 6480464 Flutamide results in increased expression of YARS1 mRNA CTD PMID:24136188 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of YARS1 mRNA, Gentamicins results in increased expression of YARS1 protein CTD PMID:22061828 , PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of YARS1 mRNA CTD PMID:24136188 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of YARS1 protein] CTD PMID:23178681 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of YARS1 protein] CTD PMID:23178681 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of YARS1 protein CTD PMID:23178681 ibuprofen increases expression ISO RGD:1316914 6480464 Ibuprofen results in increased expression of YARS1 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:1316914 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1316914 6480464 Ivermectin results in decreased expression of YARS1 protein CTD PMID:32959892 lamivudine multiple interactions ISO RGD:1316914 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA CTD PMID:15784690 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of YARS1 mRNA CTD PMID:11578147 leflunomide increases expression ISO RGD:1316914 6480464 Leflunomide results in increased expression of YARS1 mRNA CTD PMID:28988120 mercury dibromide increases expression ISO RGD:1316914 6480464 mercuric bromide results in increased expression of YARS1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1316914 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of YARS1 mRNA CTD PMID:16507785 metformin increases expression EXP 6480464 Metformin results in increased expression of YARS1 mRNA CTD PMID:25596134 methylmercury chloride increases expression ISO RGD:1316914 6480464 methylmercuric chloride results in increased expression of YARS1 mRNA CTD PMID:23179753 , PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO RGD:1316914 6480464 1-Methyl-4-phenylpyridinium results in increased expression of YARS1 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of YARS1 mRNA CTD PMID:28801915 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of YARS1 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1316914 6480464 Nickel results in increased expression of YARS1 mRNA CTD PMID:24768652 ochratoxin A increases methylation ISO RGD:1316914 6480464 ochratoxin A results in increased methylation of YARS1 promoter CTD PMID:30559759 ochratoxin A decreases expression ISO RGD:1316914 6480464 ochratoxin A results in decreased expression of YARS1 mRNA CTD PMID:30559759 p-chloromercuribenzoic acid increases expression ISO RGD:1316914 6480464 p-Chloromercuribenzoic Acid results in increased expression of YARS1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1316914 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1316914 6480464 Acetaminophen results in decreased expression of YARS1 mRNA CTD PMID:25596134 paracetamol affects expression ISO RGD:1316915 6480464 Acetaminophen affects the expression of YARS1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of YARS1 mRNA CTD PMID:32479839 paracetamol increases expression ISO RGD:1316914 6480464 Acetaminophen results in increased expression of YARS1 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of YARS1 mRNA CTD PMID:32680482 perfluorononanoic acid increases expression ISO RGD:1316914 6480464 perfluoro-n-nonanoic acid results in increased expression of YARS1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1316915 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YARS1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of YARS1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1316914 6480464 perfluorooctane sulfonic acid results in increased expression of YARS1 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1316914 6480464 perfluorooctanoic acid results in increased expression of YARS1 mRNA, perfluorooctanoic acid results in increased expression of YARS1 protein CTD PMID:26879310 , PMID:32588087 phenobarbital increases expression ISO RGD:1316914 6480464 Phenobarbital results in increased expression of YARS1 mRNA CTD PMID:19084549 phenobarbital affects expression ISO RGD:1316914 6480464 Phenobarbital affects the expression of YARS1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1316914 6480464 Phenylmercuric Acetate results in increased expression of YARS1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1316914 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA CTD PMID:27188386 phorone affects expression EXP 6480464 phorone affects the expression of YARS1 mRNA CTD PMID:18198479 potassium chromate multiple interactions ISO RGD:1316914 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of YARS1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1316914 6480464 potassium chromate(VI) results in increased expression of YARS1 mRNA CTD PMID:22079256 resveratrol multiple interactions ISO RGD:1316915 6480464 1-(4-dimethylaminomethylphenyl)-8 more ... CTD PMID:25533949 resveratrol multiple interactions ISO RGD:1316914 6480464 [Resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]] which results in increased ADP-ribosylation of PARP1 protein more ... CTD PMID:25533949 resveratrol affects localization ISO RGD:1316914 6480464 Resveratrol affects the localization of YARS1 protein CTD PMID:25533949 rotenone increases expression EXP 6480464 Rotenone results in increased expression of YARS1 protein CTD PMID:35544339 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1316914 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of YARS1 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1316914 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions ISO RGD:1316914 6480464 sodium arsenite promotes the reaction [YARS1 protein binds to CAPRIN1 protein] CTD PMID:33939924 sulforaphane multiple interactions ISO RGD:1316915 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of YARS1 mRNA CTD PMID:30529165 sunitinib increases expression ISO RGD:1316914 6480464 Sunitinib results in increased expression of YARS1 mRNA CTD PMID:31533062 tanespimycin multiple interactions ISO RGD:1316914 6480464 [tanespimycin co-treated with VER 155008] results in decreased expression of YARS1 protein CTD PMID:31370342 tetrachloroethene increases expression ISO RGD:1316915 6480464 Tetrachloroethylene results in increased expression of YARS1 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YARS1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of YARS1 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:1316914 6480464 Thapsigargin results in increased expression of YARS1 mRNA, Thapsigargin results in increased expression of YARS1 protein CTD PMID:22378314 , PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of YARS1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1316915 6480464 titanium dioxide results in decreased expression of YARS1 mRNA CTD PMID:23409001 tolcapone increases expression EXP 6480464 Tolcapone results in increased expression of YARS1 mRNA CTD PMID:24136188 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of YARS1 mRNA CTD PMID:33387578 troglitazone decreases expression EXP 6480464 Troglitazone results in decreased expression of YARS1 mRNA CTD PMID:25596134 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of YARS1 mRNA CTD PMID:24136188 tunicamycin increases expression ISO RGD:1316914 6480464 Tunicamycin results in increased expression of YARS1 mRNA, Tunicamycin results in increased expression of YARS1 protein CTD PMID:22378314 , PMID:29453283 valproic acid decreases methylation ISO RGD:1316914 6480464 Valproic Acid results in decreased methylation of YARS1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1316915 6480464 Valproic Acid affects the expression of YARS1 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1316914 6480464 Valproic Acid results in increased expression of YARS1 mRNA CTD PMID:23179753 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of YARS1 mRNA CTD PMID:22570695 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of YARS1 mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1316914 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA CTD PMID:15784690 zoledronic acid decreases expression ISO RGD:1316914 6480464 Zoledronic Acid results in decreased expression of YARS1 mRNA CTD PMID:25596134
